A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines
NCT00002402
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV Infections
Interventions
BIOLOGICAL:
MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
BIOLOGICAL:
MN rgp120/HIV-1 and A244 rgp120/HIV-1
BIOLOGICAL:
Aluminum hydroxide
Sponsor
VaxGen